(PDF) Can Diffusion-Weighted MRI Determine Complete

Can Diffusion-Weighted MRI Determine Complete Responders After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer?

Diagnostic and Interventional Radiology - Turkey

doi 10.4261/1305-3825.dir.5755-12.1

Full Text

Abstract

Available in full text

Categories

Nuclear Medicine

Cardiovascular Medicine

Date

January 1, 2012

Authors

Esra Kaytan Saglam

Publisher

AVES Publishing Co.

Related search

Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer

Clinical Oncology

Nuclear Medicine

English

Effect of Adding mFOLFOX6 After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Multicentre, Phase 2 Trial

The Lancet Oncology

English

Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Frontiers in Oncology

Cancer Research

English

Endoscopic Criteria for Evaluating Tumor Stage After Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer

Cancer Research and Treatment

Cancer Research

English

Timing of Surgery After Neoadjuvant Chemoradiation in Locally Advanced Non–Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

The Role of MRI With Diffusion-Weighted Imaging in Restaging Rectal Cancers After Neoadjuvant Chemoradiotherapy

South African Journal of Radiology

Nuclear Medicine

Ultrasound Technology

English

Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

Journal of Oncology

English

Recent Advances in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Journal of the Anus, Rectum and Colon

English